Contributors

Dr. Sandra Mitic
Life/Health Chief Medical Officer, Cologne

Dr. Sandra Mitic is the Chief Medical Officer for Life/Health Client Services, based in Cologne. She is a specialized visceral and gastroenterological surgeon and has worked as a Medical Consultant in various hospitals in Germany. She also holds a master’s degree in Public Health. Before joining Gen Re, she worked as a Medical Consultant in the private health insurance sector in Germany and the Federal Office of Civil Protection and Disaster Assistance. At Gen Re, she advises in the areas of risk and claims assessment and supports further development of risk assessment manuals and insurance products.
-
Forward Steps in the World of Orthopaedics - A Look at Emerging Trends
By Dr. Sandra Mitic Aug 27, 2019 English
New technologies are transforming the world of medicine, including the field of orthopaedics and trauma. The years to come promise even greater advances, given developments in materials science, computer-simulation and robotics. The positive effects of...
Read More -
Die Auswirkungen aktueller technologischer Trends auf die Orthopädie
By Dr. Sandra Mitic Aug 27, 2019 Deutsch
Neue Technologien führen zu einem Wandel in der Medizin, so zum Beispiel in der Orthopädie und der Chirurgie. Angesichts aktueller Entwicklungen auf dem Gebiet der Materialwissenschaft, Computersimulation und Robotik ist für die kommenden Jahre mit noch...
Read More -
New Methods of Treating Prostate Cancer
By Dr. Sandra Mitic Jul 23, 2019 English
With around 60,000 new cases per year, prostate cancer is the most common type of cancer in men in Germany. The incidence of prostate cancer - especially the early stages - has been increasing steadily for years. This is also due to early detection methods,...
Read More -
Neue Techniken um den Krebs auszulöschen - Behandlungsmöglichkeiten des Prostatakarzinoms
By Dr. Sandra Mitic Jul 23, 2019 Deutsch
Das Prostatakarzinom ist mit etwa 60.000 Neuerkrankungen/Jahr die häufigste Krebserkrankung bei Männern in Deutschland. Die Häufigkeit von Prostatakrebs nimmt vor allem in den frühen Stadien seit Jahren stetig zu. Dies ist auch auf den Einsatz der Methoden...
Read More